Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6580948rdf:typepubmed:Citationlld:pubmed
pubmed-article:6580948lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:6580948lifeskim:mentionsumls-concept:C0002699lld:lifeskim
pubmed-article:6580948lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:6580948lifeskim:mentionsumls-concept:C0220836lld:lifeskim
pubmed-article:6580948lifeskim:mentionsumls-concept:C0205269lld:lifeskim
pubmed-article:6580948pubmed:issue12lld:pubmed
pubmed-article:6580948pubmed:dateCreated1984-2-14lld:pubmed
pubmed-article:6580948pubmed:abstractTextTwenty-six adults with refractory leukemia were treated with amsacrine gluconate, a new formulation. There were two complete and two partial remissions. This preparation has no apparent advantage when compared with amsacrine lactate.lld:pubmed
pubmed-article:6580948pubmed:languageenglld:pubmed
pubmed-article:6580948pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6580948pubmed:citationSubsetIMlld:pubmed
pubmed-article:6580948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6580948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6580948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6580948pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6580948pubmed:statusMEDLINElld:pubmed
pubmed-article:6580948pubmed:monthDeclld:pubmed
pubmed-article:6580948pubmed:issn0361-5960lld:pubmed
pubmed-article:6580948pubmed:authorpubmed-author:VoglerW RWRlld:pubmed
pubmed-article:6580948pubmed:authorpubmed-author:OmuraG AGAlld:pubmed
pubmed-article:6580948pubmed:authorpubmed-author:WintonE FEFlld:pubmed
pubmed-article:6580948pubmed:authorpubmed-author:ZuckermanK...lld:pubmed
pubmed-article:6580948pubmed:authorpubmed-author:Grillo-LopezA...lld:pubmed
pubmed-article:6580948pubmed:issnTypePrintlld:pubmed
pubmed-article:6580948pubmed:volume67lld:pubmed
pubmed-article:6580948pubmed:ownerNLMlld:pubmed
pubmed-article:6580948pubmed:authorsCompleteYlld:pubmed
pubmed-article:6580948pubmed:pagination1131-2lld:pubmed
pubmed-article:6580948pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:meshHeadingpubmed-meshheading:6580948-...lld:pubmed
pubmed-article:6580948pubmed:year1983lld:pubmed
pubmed-article:6580948pubmed:articleTitlePhase II study of amsacrine gluconate in refractory leukemia.lld:pubmed
pubmed-article:6580948pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6580948pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6580948lld:pubmed